prazosin has been researched along with Cat Diseases in 6 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Cat Diseases: Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to determine if male cats treated with 7 days of prazosin following relief of urethral obstruction (UO) experienced decreased rates of recurrent urethral obstruction (rUO) within 30 days vs those treated with 7 days of placebo." | 9.41 | Effect of prazosin on feline recurrent urethral obstruction. ( Hanson, KR; Linklater, AK; Mochel, JP; Rudloff, E; Yuan, L, 2021) |
| "To determine whether prazosin administration following urethral obstruction (UO) reduces the risk for recurrent urethral obstruction (rUO) or lower urinary tract signs, and to document adverse effects associated with prazosin use in cats." | 9.24 | The effect of prazosin on outcome in feline urethral obstruction. ( Drobatz, KJ; Reineke, EL; Savini, J; Syring, RS; Thomas, EK, 2017) |
| "To determine if prazosin administration decreased the rate of recurrent urethral obstruction (rUO) before hospital discharge and within 14 days." | 8.12 | Prazosin administration increases the rate of recurrent urethral obstruction in cats: 388 cases. ( Conway, DS; Rozanski, EA; Wayne, AS, 2022) |
| "The aim of this study was to determine if male cats treated with 7 days of prazosin following relief of urethral obstruction (UO) experienced decreased rates of recurrent urethral obstruction (rUO) within 30 days vs those treated with 7 days of placebo." | 5.41 | Effect of prazosin on feline recurrent urethral obstruction. ( Hanson, KR; Linklater, AK; Mochel, JP; Rudloff, E; Yuan, L, 2021) |
| "To determine whether prazosin administration following urethral obstruction (UO) reduces the risk for recurrent urethral obstruction (rUO) or lower urinary tract signs, and to document adverse effects associated with prazosin use in cats." | 5.24 | The effect of prazosin on outcome in feline urethral obstruction. ( Drobatz, KJ; Reineke, EL; Savini, J; Syring, RS; Thomas, EK, 2017) |
| "To determine if prazosin administration decreased the rate of recurrent urethral obstruction (rUO) before hospital discharge and within 14 days." | 4.12 | Prazosin administration increases the rate of recurrent urethral obstruction in cats: 388 cases. ( Conway, DS; Rozanski, EA; Wayne, AS, 2022) |
| "No difference in rUO was found in cats treated for urethral obstruction with a 3." | 1.56 | Retrospective evaluation of urinary indwelling catheter type in cats with urethral obstruction (January 2014 to December 2014): 91 cases. ( Davidow, EB, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conway, DS | 1 |
| Rozanski, EA | 1 |
| Wayne, AS | 1 |
| Davidow, EB | 1 |
| Hanson, KR | 1 |
| Rudloff, E | 1 |
| Yuan, L | 1 |
| Mochel, JP | 1 |
| Linklater, AK | 1 |
| Reineke, EL | 1 |
| Thomas, EK | 1 |
| Syring, RS | 1 |
| Savini, J | 1 |
| Drobatz, KJ | 1 |
| Ramirez, CJ | 1 |
| Minch, JD | 1 |
| Gay, JM | 1 |
| Lahmers, SM | 1 |
| Guerra, DJ | 1 |
| Haldorson, GJ | 1 |
| Schneider, T | 1 |
| Mealey, KL | 1 |
| Straeter-Knowlen, IM | 1 |
| Marks, SL | 1 |
| Rishniw, M | 1 |
| Speth, RC | 1 |
| Wirth, W | 1 |
| Knowlen, GC | 1 |
2 trials available for prazosin and Cat Diseases
| Article | Year |
|---|---|
Effect of prazosin on feline recurrent urethral obstruction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Diseases; Cats; Male; Prazosin; Recurrence; Ur | 2021 |
The effect of prazosin on outcome in feline urethral obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Cat Diseases; Cats; Double-Blind Method; Incidence | 2017 |
4 other studies available for prazosin and Cat Diseases
| Article | Year |
|---|---|
Prazosin administration increases the rate of recurrent urethral obstruction in cats: 388 cases.
Topics: Animals; Cat Diseases; Cats; Prazosin; Urethra; Urethral Obstruction | 2022 |
Retrospective evaluation of urinary indwelling catheter type in cats with urethral obstruction (January 2014 to December 2014): 91 cases.
Topics: Animals; Cat Diseases; Catheters, Indwelling; Cats; Male; Prazosin; Recurrence; Retrospective Studie | 2020 |
Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats.
Topics: Amino Acid Sequence; Animals; ATP-Binding Cassette Transporters; Base Sequence; Boron Compounds; Cat | 2011 |
Urethral pressure response to smooth and skeletal muscle relaxants in anesthetized, adult male cats with naturally acquired urethral obstruction.
Topics: Animals; Cat Diseases; Cats; Dantrolene; Drug Interactions; Male; Muscle, Smooth; Neuromuscular Depo | 1995 |